Details
- Organisation Name: Townsville University Hospital
- HHS: Townsville Hospital and Health Service (THHS)
- Services Offered: Clinical trials site;Investigator Initiated Trials;Satellite Site;Trial Patient Recruitment;Treatment of patients;Completion of study documentation as per ICH GCP and contract
- Website Address: https://www.health.qld.gov.au/townsville
- Contact: Melanie Taylor: TSV-Oncology-Clinical-Trials@health.qld.gov.au
- Other Affiliated Research Sites: Teletrial partnerships with Mackay, Cairns, Metro South
Location
-19.321099 - 146.76087
Is your Facility able to initiate study activities prior to Ethics Committee protocol approval?
No
How long before Ethics Committee review is the Submission Packet required?
2 weeks
Site Overview
Research is a core strategic pillar of Townsville Hospital and Health Service, supporting innovation, improved patient outcomes, and high-quality care. As Northern Australia’s only tertiary referral centre, the site provides access to a large and diverse regional population and offers advanced oncology clinical trial infrastructure, including teletrials and remote monitoring capabilities.
HREC
- HREC Committee Name: We will accept any public or private HREC in Australia, we also have a local committee
- Meeting frequency: Monthly (local committee)
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Central Acting as Local
- Mandate distribution of safety: Yes
- Meeting frequency: Monthly (local committee)
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Central Acting as Local
- Mandate distribution of safety: Yes
Facility staffing and training
- Handling Investigational Product: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: Yes
Licenses to receive, store, dispense and return controlled substances
- Required Licenses or Registrations: Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? Yes
Equipment
- Investigational Product: Extemporaneous Preparation
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
Patient Records
- Record Archiving: Yes, Paper records digitised and retained per Queensland Health policy
- EMR/EHR systems: ieMR (Oracle Health) with audit trail and regulatory compliance, MTiles, MasterControl eISF
- Has your Clinical Trial Site or Service been accredited? Yes
- Audit Type: Sponsor
- EMR/EHR systems: ieMR (Oracle Health) with audit trail and regulatory compliance, MTiles, MasterControl eISF
- Has your Clinical Trial Site or Service been accredited? Yes
- Audit Type: Sponsor
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Acquired Haemophilia
Acute Lymphoblastic Leukaemia
Acute Myelogenous Leukaemia
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
CAR-T cell therapy
Cellular therapies
Cervical Cancer
Chronic Lymphocytic Leukaemia
Chronic Myelogenous Leukaemia
Colorectal Cancer
Follicular Lymphoma
Gastro Intestinal Solid Tumours
Haemic and Lymphatic Diseases
Head and Neck Cancer
Hepatocellular Carcinoma
Hereditary Angioedema
HR Prostate Cancer
Islet Cell Tumours
Liver Cancer
Lung Cancer
Lymphocytic Leukaemia
Lymphoma
Malignant Pleural Mesothelioma
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Neoplasms
Neuroma
Non- Hodgkin's Lymphoma
Non-Small Cell Lung Cancer (NSCLC)
Oncology Malignances
Ovarian Cancer
Ovarian Epithelial Carcinoma
Pancreatic Cancer
Prostate Cancer
Renal Cell Carcinoma
Sarcoma
Soft Tissues Sarcomas
Squamous & Non Squamous Sarcomas
Throat Cancer
Thyroid Cancer
Study Types
Academic
Industry
Investigator
Source Document Types
Paper and Electronic
Has your Clinical Trials Site or Service been audited by:
Sponsor
Average time to start study (in calendar days)
61-90
How long prior to HREC meeting does the application need to be submitted?
2 weeks
Does the HREC committee require contract /budget approval prior to release final approval documents?
No
Does your Facility support in-patient admissions?
Yes
PK & PD specimens
Yes
Study Phase Capability
Phase I
Phase II
Phase III
Type of Diagnostic Equipment
CT Scan Computerized Tomography Scan
DXA Dual-Energy X-ray Absorptiometry or Bone Densitometry
ECG/EKG Electrocardiogram
FLRO Fluoroscopy
MAMMO Mammography
MRI Magnetic Resonance Imaging
NMED Nuclear medicine e.g. Bone scan
Other
PET Positron Emission Tomography Scan
SPECT
Thallium cardiac stress test
Thyroid scan
X-Ray
Patient Population
Adults - Ages 18-64
Geriatrics 65 and onwards